Relapsed/Refractory B- Cell Non-Hodgkin Lymphoma Clinical Trials in Shanghai

The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma